These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 21397090)

  • 1. Severity of infection following the introduction of new infection control measures for medical abortion.
    Fjerstad M; Trussell J; Lichtenberg ES; Sivin I; Cullins V
    Contraception; 2011 Apr; 83(4):330-5. PubMed ID: 21397090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction in infection-related mortality since modifications in the regimen of medical abortion.
    Trussell J; Nucatola D; Fjerstad M; Lichtenberg ES
    Contraception; 2014 Mar; 89(3):193-6. PubMed ID: 24405798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rates of serious infection after changes in regimens for medical abortion.
    Fjerstad M; Trussell J; Sivin I; Lichtenberg ES; Cullins V
    N Engl J Med; 2009 Jul; 361(2):145-51. PubMed ID: 19587339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of medical abortion with mifepristone and buccal misoprostol through 59 gestational days.
    Fjerstad M; Sivin I; Lichtenberg ES; Trussell J; Cleland K; Cullins V
    Contraception; 2009 Sep; 80(3):282-6. PubMed ID: 19698822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two distinct oral routes of misoprostol in mifepristone medical abortion: a randomized controlled trial.
    Winikoff B; Dzuba IG; Creinin MD; Crowden WA; Goldberg AB; Gonzales J; Howe M; Moskowitz J; Prine L; Shannon CS
    Obstet Gynecol; 2008 Dec; 112(6):1303-1310. PubMed ID: 19037040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose mifepristone 200 mg and vaginal misoprostol for abortion.
    Schaff EA; Eisinger SH; Stadalius LS; Franks P; Gore BZ; Poppema S
    Contraception; 1999 Jan; 59(1):1-6. PubMed ID: 10342079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized trial of mifepristone and buccal or vaginal misoprostol for abortion through 56 days of last menstrual period.
    Middleton T; Schaff E; Fielding SL; Scahill M; Shannon C; Westheimer E; Wilkinson T; Winikoff B
    Contraception; 2005 Nov; 72(5):328-32. PubMed ID: 16246656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mifepristone followed by home administration of buccal misoprostol for medical abortion up to 70 days of amenorrhoea in a general practice in Curaçao.
    Boersma AA; Meyboom-de Jong B; Kleiverda G
    Eur J Contracept Reprod Health Care; 2011 Apr; 16(2):61-6. PubMed ID: 21303309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early medical abortion using low-dose mifepristone followed by buccal misoprostol: a large Australian observational study.
    Goldstone P; Michelson J; Williamson E
    Med J Aust; 2012 Sep; 197(5):282-6. PubMed ID: 22938126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized controlled trial of different buccal misoprostol doses in mifepristone medical abortion.
    Chong E; Tsereteli T; Nguyen NN; Winikoff B
    Contraception; 2012 Sep; 86(3):251-6. PubMed ID: 22305917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral mifepristone and buccal misoprostol administered simultaneously for abortion: a pilot study.
    Lohr PA; Reeves MF; Hayes JL; Harwood B; Creinin MD
    Contraception; 2007 Sep; 76(3):215-20. PubMed ID: 17707719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized clinical trial comparing the short-term side effects of sublingual and buccal routes of misoprostol administration for medical abortions up to 63 days' gestation.
    Chai J; Wong CY; Ho PC
    Contraception; 2013 Apr; 87(4):480-5. PubMed ID: 23102797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rates of serious infection after medical abortion.
    Kapp N; Winikoff B; Blumenthal PD
    N Engl J Med; 2009 Oct; 361(15):1511-2; author reply 1512. PubMed ID: 19812412
    [No Abstract]   [Full Text] [Related]  

  • 14. A double-blind randomized controlled trial of mifepristone or placebo before buccal misoprostol for abortion at 14-21 weeks of pregnancy.
    Dabash R; Chelli H; Hajri S; Shochet T; Raghavan S; Winikoff B
    Int J Gynaecol Obstet; 2015 Jul; 130(1):40-4. PubMed ID: 25896965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How much supervision is necessary for women taking mifepristone and misoprostol for early medical abortion?
    Shannon C; Winikoff B
    Womens Health (Lond); 2008 Mar; 4(2):107-11. PubMed ID: 19072508
    [No Abstract]   [Full Text] [Related]  

  • 16. Second trimester medical abortion with mifepristone-misoprostol and misoprostol alone: a review of methods and management.
    Gemzell-Danielsson K; Lalitkumar S
    Reprod Health Matters; 2008 May; 16(31 Suppl):162-72. PubMed ID: 18772097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mifepristone plus vaginal misoprostol vs vaginal misoprostol alone for medical abortion in gestation 63 days or less in Nepalese women: a quasi-randomized controlled trial.
    Chawdhary R; Rana A; Pradhan N
    J Obstet Gynaecol Res; 2009 Feb; 35(1):78-85. PubMed ID: 19215552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and acceptability of a mifepristone-misoprostol combined regimen for early induced abortion among women in Mexico City.
    Peña M; Dzuba IG; Smith PS; Mendoza LJ; Bousiéguez M; Martínez ML; Polanco RR; Villalón AE; Winikoff B
    Int J Gynaecol Obstet; 2014 Oct; 127(1):82-5. PubMed ID: 24957534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Misoprostol dose and route after mifepristone for early medical abortion: a randomised controlled noninferiority trial.
    von Hertzen H; Huong NT; Piaggio G; Bayalag M; Cabezas E; Fang AH; Gemzell-Danielsson K; Hinh ND; Mittal S; Ng EH; Chaturachinda K; Pinter B; Puscasiu L; Savardekar L; Shenoy S; Khomassuridge A; Tuyet HT; Velasco A; Peregoudov A;
    BJOG; 2010 Sep; 117(10):1186-96. PubMed ID: 20560941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective randomized, double-blinded, placebo-controlled trial comparing mifepristone and vaginal misoprostol to vaginal misoprostol alone for elective termination of early pregnancy.
    Jain JK; Dutton C; Harwood B; Meckstroth KR; Mishell DR
    Hum Reprod; 2002 Jun; 17(6):1477-82. PubMed ID: 12042265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.